vs
PATHWARD FINANCIAL, INC.（CASH）与CORCEPT THERAPEUTICS INC（CORT）财务数据对比。点击上方公司名可切换其他公司
PATHWARD FINANCIAL, INC.的季度营收约是CORCEPT THERAPEUTICS INC的1.4倍（$276.3M vs $202.1M），PATHWARD FINANCIAL, INC.净利率更高（26.4% vs 12.0%，领先14.4%），过去两年PATHWARD FINANCIAL, INC.的营收复合增速更高（21.0% vs 17.3%）
Pathward Financial, Inc.是一家总部位于美国的银行及金融服务企业，其前身为Meta金融集团旗下相关业务主体，2022年母公司将“Meta”商标出售给Meta Platforms后，正式启用现有名称。
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
CASH vs CORT — 直观对比
营收规模更大
CASH
是对方的1.4倍
$202.1M
净利率更高
CASH
高出14.4%
12.0%
两年增速更快
CASH
近两年复合增速
17.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $276.3M | $202.1M |
| 净利润 | $72.9M | $24.3M |
| 毛利率 | — | 98.7% |
| 营业利润率 | — | 2.2% |
| 净利率 | 26.4% | 12.0% |
| 营收同比 | — | 11.1% |
| 净利润同比 | — | -21.0% |
| 每股收益（稀释后） | $3.35 | $0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CASHCORT
| Q1 26 | $276.3M | — | ||
| Q4 25 | $173.1M | $202.1M | ||
| Q3 25 | $186.7M | $207.6M | ||
| Q2 25 | $195.8M | $194.4M | ||
| Q1 25 | $274.8M | $157.2M | ||
| Q4 24 | $182.6M | $181.9M | ||
| Q3 24 | $179.5M | $182.5M | ||
| Q2 24 | $188.6M | $163.8M |
净利润CASHCORT
| Q1 26 | $72.9M | — | ||
| Q4 25 | $35.2M | $24.3M | ||
| Q3 25 | $38.8M | $19.7M | ||
| Q2 25 | $42.1M | $35.1M | ||
| Q1 25 | $75.0M | $20.5M | ||
| Q4 24 | $30.0M | $30.7M | ||
| Q3 24 | $33.5M | $47.2M | ||
| Q2 24 | $44.9M | $35.5M |
毛利率CASHCORT
| Q1 26 | — | — | ||
| Q4 25 | — | 98.7% | ||
| Q3 25 | — | 97.8% | ||
| Q2 25 | — | 98.2% | ||
| Q1 25 | — | 98.5% | ||
| Q4 24 | — | 98.4% | ||
| Q3 24 | — | 98.4% | ||
| Q2 24 | — | 98.5% |
营业利润率CASHCORT
| Q1 26 | — | — | ||
| Q4 25 | 24.6% | 2.2% | ||
| Q3 25 | 25.9% | 4.9% | ||
| Q2 25 | 24.1% | 13.7% | ||
| Q1 25 | 33.2% | 2.2% | ||
| Q4 24 | 19.8% | 13.9% | ||
| Q3 24 | 20.9% | 25.5% | ||
| Q2 24 | 27.1% | 21.7% |
净利率CASHCORT
| Q1 26 | 26.4% | — | ||
| Q4 25 | 20.3% | 12.0% | ||
| Q3 25 | 20.8% | 9.5% | ||
| Q2 25 | 21.5% | 18.1% | ||
| Q1 25 | 27.3% | 13.1% | ||
| Q4 24 | 16.4% | 16.9% | ||
| Q3 24 | 18.7% | 25.9% | ||
| Q2 24 | 23.8% | 21.7% |
每股收益（稀释后）CASHCORT
| Q1 26 | $3.35 | — | ||
| Q4 25 | $1.57 | $0.20 | ||
| Q3 25 | $1.69 | $0.16 | ||
| Q2 25 | $1.81 | $0.29 | ||
| Q1 25 | $3.14 | $0.17 | ||
| Q4 24 | $1.23 | $0.25 | ||
| Q3 24 | $1.34 | $0.41 | ||
| Q2 24 | $1.78 | $0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $157.6M | $372.2M |
| 总债务越低越好 | $59.5M | — |
| 股东权益账面价值 | $850.7M | $647.8M |
| 总资产 | $7.1B | $836.7M |
| 负债/权益比越低杠杆越低 | 0.07× | — |
8季度趋势，按日历期对齐
现金及短期投资CASHCORT
| Q1 26 | $157.6M | — | ||
| Q4 25 | $331.2M | $372.2M | ||
| Q3 25 | $120.6M | $421.7M | ||
| Q2 25 | $258.3M | $342.2M | ||
| Q1 25 | $254.2M | $322.8M | ||
| Q4 24 | $597.4M | $383.3M | ||
| Q3 24 | $158.3M | $380.3M | ||
| Q2 24 | $298.9M | $473.2M |
总债务CASHCORT
| Q1 26 | $59.5M | — | ||
| Q4 25 | $33.5M | — | ||
| Q3 25 | $33.5M | — | ||
| Q2 25 | $33.4M | — | ||
| Q1 25 | $33.4M | — | ||
| Q4 24 | $33.4M | — | ||
| Q3 24 | $33.4M | — | ||
| Q2 24 | $33.3M | — |
股东权益CASHCORT
| Q1 26 | $850.7M | — | ||
| Q4 25 | $854.5M | $647.8M | ||
| Q3 25 | $858.0M | $631.9M | ||
| Q2 25 | $819.0M | $635.8M | ||
| Q1 25 | $814.7M | $683.3M | ||
| Q4 24 | $758.3M | $679.6M | ||
| Q3 24 | $822.5M | $638.8M | ||
| Q2 24 | $748.4M | $596.2M |
总资产CASHCORT
| Q1 26 | $7.1B | — | ||
| Q4 25 | $7.6B | $836.7M | ||
| Q3 25 | $7.2B | $823.6M | ||
| Q2 25 | $7.2B | $801.7M | ||
| Q1 25 | $7.0B | $846.5M | ||
| Q4 24 | $7.6B | $840.6M | ||
| Q3 24 | $7.5B | $784.3M | ||
| Q2 24 | $7.5B | $714.6M |
负债/权益比CASHCORT
| Q1 26 | 0.07× | — | ||
| Q4 25 | 0.04× | — | ||
| Q3 25 | 0.04× | — | ||
| Q2 25 | 0.04× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.04× | — | ||
| Q3 24 | 0.04× | — | ||
| Q2 24 | 0.04× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $38.4M |
| 自由现金流经营现金流 - 资本支出 | — | $38.4M |
| 自由现金流率自由现金流/营收 | — | 19.0% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | 1.58× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CASHCORT
| Q1 26 | — | — | ||
| Q4 25 | $108.3M | $38.4M | ||
| Q3 25 | $303.7M | $54.5M | ||
| Q2 25 | $30.4M | $43.9M | ||
| Q1 25 | $188.3M | $5.1M | ||
| Q4 24 | $-71.7M | $59.3M | ||
| Q3 24 | $143.1M | $73.8M | ||
| Q2 24 | $113.2M | $41.2M |
自由现金流CASHCORT
| Q1 26 | — | — | ||
| Q4 25 | $104.1M | $38.4M | ||
| Q3 25 | $300.3M | — | ||
| Q2 25 | $27.7M | $43.9M | ||
| Q1 25 | $184.7M | $5.0M | ||
| Q4 24 | $-73.8M | $59.2M | ||
| Q3 24 | $138.8M | $72.2M | ||
| Q2 24 | $111.0M | $40.8M |
自由现金流率CASHCORT
| Q1 26 | — | — | ||
| Q4 25 | 60.1% | 19.0% | ||
| Q3 25 | 160.9% | — | ||
| Q2 25 | 14.1% | 22.6% | ||
| Q1 25 | 67.2% | 3.2% | ||
| Q4 24 | -40.4% | 32.5% | ||
| Q3 24 | 77.3% | 39.5% | ||
| Q2 24 | 58.8% | 24.9% |
资本支出强度CASHCORT
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 0.0% | ||
| Q3 25 | 1.8% | 0.0% | ||
| Q2 25 | 1.4% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 1.1% | 0.1% | ||
| Q3 24 | 2.4% | 0.9% | ||
| Q2 24 | 1.2% | 0.3% |
现金转化率CASHCORT
| Q1 26 | — | — | ||
| Q4 25 | 3.08× | 1.58× | ||
| Q3 25 | 7.83× | 2.77× | ||
| Q2 25 | 0.72× | 1.25× | ||
| Q1 25 | 2.51× | 0.25× | ||
| Q4 24 | -2.39× | 1.93× | ||
| Q3 24 | 4.27× | 1.56× | ||
| Q2 24 | 2.52× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CASH
| Noninterest Income | $151.2M | 55% |
| Net Interest Income | $125.1M | 45% |
CORT
暂无分部数据
